PIRAMAL PHARMA
|
PIRAMAL PHARMA Last 5 Year Income Statement History
[Consolidated]
Mar2023 | Mar2022 | Mar2021 | |
---|---|---|---|
INCOME : | |||
Gross Sales | ₹7,306 Cr | ₹6,315 Cr | ₹6,315 Cr |
Sales | ₹6,324 Cr | ₹5,370 Cr | ₹5,370 Cr |
Job Work/ Contract Receipts | - | - | - |
Processing Charges / Service Income | ₹854 Cr | ₹901 Cr | ₹901 Cr |
Revenue from property development | - | - | - |
Other Operational Income | ₹128 Cr | ₹45 Cr | ₹45 Cr |
Less: Excise Duty | - | - | - |
Net Sales | ₹6,559 Cr | ₹6,315 Cr | ₹6,315 Cr |
EXPENDITURE : | |||
Increase/Decrease in Stock | ₹55 Cr | ₹-53 Cr | ₹-53 Cr |
Raw Material Consumed | ₹2,396 Cr | ₹2,112 Cr | ₹2,112 Cr |
Opening Raw Materials | ₹449 Cr | ₹178 Cr | ₹178 Cr |
Purchases Raw Materials | ₹1,717 Cr | ₹1,617 Cr | ₹1,617 Cr |
Closing Raw Materials | ₹599 Cr | ₹449 Cr | ₹449 Cr |
Other Direct Purchases / Brought in cost | ₹829 Cr | ₹594 Cr | ₹594 Cr |
Other raw material cost | - | ₹172 Cr | ₹172 Cr |
Power & Fuel Cost | ₹164 Cr | ₹137 Cr | ₹137 Cr |
Electricity & Power | ₹164 Cr | ₹137 Cr | ₹137 Cr |
Oil, Fuel & Natural gas | - | - | - |
Coals etc | - | - | - |
Other power & fuel | - | - | - |
Employee Cost | ₹1,589 Cr | ₹1,468 Cr | ₹1,468 Cr |
Salaries, Wages & Bonus | ₹1,368 Cr | ₹1,241 Cr | ₹1,241 Cr |
Contributions to EPF & Pension Funds | ₹102 Cr | ₹98 Cr | ₹98 Cr |
Workmen and Staff Welfare Expenses | ₹115 Cr | ₹123 Cr | ₹123 Cr |
Other Employees Cost | ₹3.81 Cr | ₹5.12 Cr | ₹5.12 Cr |
Other Manufacturing Expenses | ₹589 Cr | ₹544 Cr | ₹544 Cr |
Sub-contracted / Out sourced services | - | - | - |
Processing Charges | ₹12 Cr | ₹11 Cr | ₹11 Cr |
Repairs and Maintenance | ₹220 Cr | ₹187 Cr | ₹187 Cr |
Packing Material Consumed | - | - | - |
Other Mfg Exp | ₹357 Cr | ₹345 Cr | ₹345 Cr |
General and Administration Expenses | ₹428 Cr | ₹367 Cr | ₹367 Cr |
Rent , Rates & Taxes | ₹102 Cr | ₹74 Cr | ₹74 Cr |
Insurance | ₹43 Cr | ₹37 Cr | ₹37 Cr |
Printing and stationery | ₹45 Cr | ₹7.82 Cr | ₹7.82 Cr |
Professional and legal fees | ₹136 Cr | ₹122 Cr | ₹122 Cr |
Traveling and conveyance | ₹35 Cr | ₹22 Cr | ₹22 Cr |
Other Administration | ₹103 Cr | ₹126 Cr | ₹126 Cr |
Selling and Distribution Expenses | ₹318 Cr | ₹248 Cr | ₹248 Cr |
Advertisement & Sales Promotion | ₹151 Cr | ₹103 Cr | ₹103 Cr |
Sales Commissions & Incentives | - | - | - |
Freight and Forwarding | ₹133 Cr | ₹110 Cr | ₹110 Cr |
Handling and Clearing Charges | ₹32 Cr | ₹35 Cr | ₹35 Cr |
Other Selling Expenses | ₹1.18 Cr | - | - |
Miscellaneous Expenses | ₹70 Cr | ₹64 Cr | ₹64 Cr |
Bad debts /advances written off | - | - | - |
Provision for doubtful debts | ₹1.16 Cr | - | - |
Losson disposal of fixed assets(net) | ₹7.98 Cr | ₹5.74 Cr | ₹5.74 Cr |
Losson foreign exchange fluctuations | - | - | - |
Losson sale of non-trade current investments | - | - | - |
Other Miscellaneous Expenses | ₹61 Cr | ₹58 Cr | ₹58 Cr |
Less: Expenses Capitalised | - | - | - |
Total Expenditure | ₹5,609 Cr | ₹4,887 Cr | ₹4,887 Cr |
Operating Profit (Excl OI) | ₹950 Cr | ₹1,428 Cr | ₹1,428 Cr |
Other Income | ₹276 Cr | ₹164 Cr | ₹164 Cr |
Interest Received | ₹0.68 Cr | ₹4.02 Cr | ₹4.02 Cr |
Dividend Received | - | - | - |
Profit on sale of Fixed Assets | - | ₹1.14 Cr | ₹1.14 Cr |
Profits on sale of Investments | ₹1.95 Cr | - | - |
Provision Written Back | ₹60 Cr | ₹6.74 Cr | ₹6.74 Cr |
Foreign Exchange Gains | ₹17 Cr | ₹61 Cr | ₹61 Cr |
Others | ₹196 Cr | ₹91 Cr | ₹91 Cr |
Operating Profit | ₹1,225 Cr | ₹1,592 Cr | ₹1,592 Cr |
Interest | ₹198 Cr | ₹163 Cr | ₹163 Cr |
InterestonDebenture / Bonds | - | - | - |
Interest on Term Loan | - | - | - |
Intereston Fixed deposits | - | - | - |
Bank Charges etc | ₹9.47 Cr | ₹5.43 Cr | ₹5.43 Cr |
Other Interest | ₹189 Cr | ₹158 Cr | ₹158 Cr |
PBDT | ₹1,027 Cr | ₹1,429 Cr | ₹1,429 Cr |
Depreciation | ₹586 Cr | ₹545 Cr | ₹545 Cr |
Profit Before Taxation & Exceptional Items | ₹441 Cr | ₹884 Cr | ₹884 Cr |
Exceptional Income / Expenses | ₹-15 Cr | ₹18 Cr | ₹18 Cr |
Profit Before Tax | ₹485 Cr | ₹949 Cr | ₹949 Cr |
Provision for Tax | ₹109 Cr | ₹114 Cr | ₹114 Cr |
Current Income Tax | ₹191 Cr | ₹116 Cr | ₹116 Cr |
Deferred Tax | ₹-82 Cr | ₹-2.32 Cr | ₹-2.32 Cr |
Other taxes | - | - | - |
Profit After Tax | ₹376 Cr | ₹835 Cr | ₹835 Cr |
Extra items | - | - | - |
Minority Interest | - | - | - |
Share of Associate | - | - | - |
Other Consolidated Items | - | - | - |
Consolidated Net Profit | ₹376 Cr | ₹835 Cr | ₹835 Cr |
Adjustments to PAT | - | - | - |
Profit Balance B/F | ₹833 Cr | - | - |
Appropriations | ₹1,209 Cr | ₹835 Cr | ₹835 Cr |
General Reserves | - | - | - |
Proposed Equity Dividend | - | - | - |
Corporate dividend tax | - | - | - |
Other Appropriation | ₹50 Cr | ₹2.47 Cr | ₹2.47 Cr |
Equity Dividend % | - | - | - |
Earnings Per Share | ₹3.17 | ₹8.40 | ₹8.40 |
Adjusted EPS | ₹3.17 | ₹8.40 | ₹8.40 |
Compare Income Statement of peers of PIRAMAL PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
PIRAMAL PHARMA | ₹19,711.2 Cr | -3% | 2.8% | 108.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹370,757.0 Cr | 1.6% | -3.7% | 60% | Stock Analytics | |
CIPLA | ₹109,559.0 Cr | -2% | -4.6% | 49.9% | Stock Analytics | |
DIVIS LABORATORIES | ₹103,416.0 Cr | -0.9% | 4.2% | 14.3% | Stock Analytics | |
ZYDUS LIFESCIENCES | ₹99,088.9 Cr | -2.1% | -0.9% | 89.1% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹97,939.0 Cr | -3.1% | -4.7% | 21.6% | Stock Analytics |
PIRAMAL PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
PIRAMAL PHARMA | -3% |
2.8% |
108.3% |
SENSEX | -0.6% |
-2.1% |
18.4% |
You may also like the below Video Courses